Cargando…
Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy
In recent years, immunotherapy has become the most promising therapy for a variety of cancer types. The development of immune checkpoint blockade (ICB) therapies, the adoptive transfer of tumor-specific T cells (adoptive cell therapy (ACT)) or the generation of T cells engineered with chimeric antig...
Autores principales: | Ginefra, Pierpaolo, Lorusso, Girieca, Vannini, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352556/ https://www.ncbi.nlm.nih.gov/pubmed/32580431 http://dx.doi.org/10.3390/ijms21124441 |
Ejemplares similares
-
Ionic Regulation of T-Cell Function and Anti-Tumour Immunity
por: Ginefra, Pierpaolo, et al.
Publicado: (2021) -
TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8(+) T cells
por: Hope, Helen Carrasco, et al.
Publicado: (2022) -
Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
por: Albini, Adriana, et al.
Publicado: (2009) -
Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
por: Lorusso, Girieca, et al.
Publicado: (2020) -
Nanomaterials for modulating innate immune cells in cancer immunotherapy
por: Le, Quoc-Viet, et al.
Publicado: (2019)